Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-11

Clinical Trial Update: Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating whether a defined green tea catechin extract can prevent esophageal cancer in patients with Barrett's esophagus has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Green tea catechin extract (green tea catechin extract)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Barrett Esophagus | Phase 1 | Status: COMPLETED